Trial Profile
Infusion VErsus STimulation, a cost-effectiveness analysis of the treatment in advanced Parkinson's disease comparing Continuous Intrajejunal Levodopa Infusion to the traditional standard treetment Deep Brain Stimulation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Feb 2024
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms INVEST
- 13 Feb 2024 Status changed from active, no longer recruiting to completed.
- 20 Apr 2022 Status changed from recruiting to active, no longer recruiting.
- 20 Jan 2019 Planned End Date changed from 1 Dec 2018 to 1 Dec 2023.